Identification of the breast cancer susceptibility gene BRCA2

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Nature

• Publication date

  1996-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/379749A0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Depletion of BRCA1 Potentiates Progestin-Induced Cytoskeletal Changes in an Ovarian Cancer Cell Model

  2026cites this paper
• New genomic and proteomic biomarker discovery in cancer: revolutionizing diagnosis and prognostication

  2026cites this paper
• Identification of BRCA1 and BRCA2 Germline Mutations in Female Breast Cancer Patients Using Next Generation Sequencing.

  2026cites this paper
• Optimizing endocrine adjuvant therapy in HR+/HER2− breast cancer: supplemental strategies and innovations

  2025cites this paper
• Causal relationship between breast cancer and acute myeloid leukemia based on two-sample bidirectional Mendelian randomization and transcriptome overlap analysis

  2025cites this paper
• Redefining Risk, Biomarkers, and Precision Therapy for Hereditary Ovarian Cancer: A Review

  2025cites this paper
• Nanomaterial-Enhanced Electrochemical Biosensing of Breast Cancer Biomarkers: A Review of Innovations in Materials, Mechanisms, and Clinical Potential

  2025cites this paper
• Survival outcomes in hormone receptor-negative breast cancer among BRCA carriers versus noncarriers in western Sweden

  2025cites this paper
• Estimating Cancer Penetrance in Carriers of BRCA2 Pathogenic Variants Using Cancer‐Specific Polygenic Scores

  2025cites this paper
• Complete remission with olaparib in BRIP1-mutated metastatic high-grade pleomorphic sarcoma: case study and literature review – an example of a genomic profiling-based tumor treatment, in a cancer type with high unmet clinical need

  2025cites this paper
• BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality

  2024cites this paper
• Exploring Somatic Genomic Alterations in Breast Cancer: Insights from the 100,000 Genomes Project at a Tertiary Care Breast Cancer Centre

  2024cites this paper
• Implementing the Risk Stratification and Clinical Management of Breast Cancer Families Using Polygenic Risk Score Evaluation: A Pilot Study

  2024cites this paper
• Hereditary Cancer Genetic Testing

  2024cites this paper
• Prognostic significance of BRCA1 and BRCA2 methylation status in circulating cell-free DNA of Pancreatic Cancer patients

  2024cites this paper
• An overview of lncRNA NEAT1 contribution in the pathogenesis of female cancers; from diagnosis to therapy resistance.

  2024cites this paper
• Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients

  2024cites this paper
• Association of Gene Variant Type and Location with Breast Cancer Risk in the General Population

  2024cites this paper
• Biomarkers for Early Cancer Detection: A Landscape View of Recent Advancements, Spotlighting Pancreatic and Liver Cancers

  2024cites this paper
• Metastatic breast cancer with double heterozygosity for the BRCA1 and BRCA2 genes responding to olaparib: A case report

  2024influential citation
• BRCA Mutation in Ovarian Cancer: Implications for Screening, Diagnosis, and Preventive Measures

  2024cites this paper
• Genetic associations with human longevity are enriched for oncogenic genes

  2024cites this paper
• Induction of the DNA-Repair Gene POLQ only in BRCA1-mutant Breast-Cancer Cells by Methionine Restriction

  2024cites this paper
• Untapped Potential of Poly(ADP-Ribose) Polymerase Inhibitors: Lessons Learned From the Real-World Clinical Homologous Recombination Repair Mutation Testing

  2024cites this paper
• Understanding the Hereditary Factors in Cancer- Recent Insights and Developments: An Updated Review

  2023cites this paper
• A Postpartum Breast Cancer Diagnosis Reduces Survival in Germline BRCA pathogenic variant Carriers

  2023cites this paper
• Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene

  2023cites this paper
• Inflammatory cytokine‐enriched microenvironment plays key roles in the development of breast cancers

  2023cites this paper
• BRCA2 promotes genomic integrity and therapy resistance primarily through its role in homology-directed repair

  2023cites this paper
• Two novel variants in the 3’UTR of the gene in familial breast and/or ovarian cancer

  2023cites this paper
• Becker Digital Commons

  2023cites this paper
• Mammary Tumors in Dogs, Recent Perspectives and Antiangiogenesis as a Therapeutic Strategy: Literature Study

  2023cites this paper
• Common hotspots of cancer chemotherapy

  2023cites this paper
• Rare germline genetic variation in PAX8 transcription factor binding sites and susceptibility to epithelial ovarian cancer

  2023cites this paper
• Cis- and trans-eQTL TWAS of breast and ovarian cancer identify more than 100 risk associated genes in the BCAC and OCAC consortia

  2023cites this paper
• Genetically engineered mouse models for hereditary cancer syndromes

  2023cites this paper
• Counselling and management of women with genetic predisposition to gynaecological cancers.

  2023cites this paper
• REPRODUCIBLE AND CLINICALLY TRANSLATABLE DEEP NEURAL NETWORKS FOR CANCER SCREENING

  2023cites this paper
• BRCA Mutations and Fertility Preservation

  2023cites this paper
• The Tumor Suppressor BRCA1/2, Cancer Susceptibility and Genome Instability in Gynecological and Mammary Cancers

  2023cites this paper
• CLINICAL CASE: SYNCHRONOUS MALIGNANCY: LEFT BREAST AND OVARIAN CANCER ASSOCIATED WITH HEREDITARY BRCA1: 5382 INS C - MUTATION

  2023cites this paper
• A Genetic Revolution: Cancer Genetic Testing and Counseling.

  2023cites this paper
• Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?

  2022cites this paper
• Carcinogenic Potential Of Ovulation Stimulation In BRCA1/2 Gene Mutation Carriers In Assisted Reproductive Technology Programs

  2022cites this paper
• Accelerating Breast Cancer Biomarker Discovery by Mass Spectrometry Proteomics and Current Bioinformatics Tools

  2022cites this paper
• Contrastive learning-based computational histopathology predict differential expression of cancer driver genes

  2022cites this paper
• Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a CancerLinQ® study

  2022cites this paper
• Pathogenic variants in the human m6A reader YTHDC2 are associated with primary ovarian insufficiency

  2022cites this paper
• BRCA2 chaperones RAD51 to single molecules of RPA-coated ssDNA

  2022cites this paper
• Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia

  2022cites this paper
• The Identification of Large Rearrangements Involving Intron 2 of the CDH1 Gene in BRCA1/2 Negative and Breast Cancer Susceptibility

  2022cites this paper
• Germline pathogenic variants associated with ovarian cancer: A historical overview

  2022cites this paper
• Rates of Variants of Uncertain Significance Among Patients With Breast Cancer Undergoing Genetic Testing: Regional Perspectives

  2022cites this paper
• Hereditary Risk Assessment for BRCA Breast and/or Ovarian Cancer

  2022cites this paper
• Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors

  2022cites this paper
• Surgical Management of Inherited Breast Cancer: Role of Breast-Conserving Surgery

  2022cites this paper
• Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center

  2022influential citation
• The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population

  2022influential citation
• Identification of novel BRCA2-binding proteins that are essential for meiotic homologous recombination

  2021cites this paper
• FOXP3 Is an X-Linked Breast Cancer Suppressor Gene and an Important Repressor of the HER-2/ErbB2 Oncogene.

  2021cites this paper
• BRCA mutated pancreatic cancer: A change is coming

  2021cites this paper
• Determination of BRCA1 and BRCA2 Gene Mutations in Patients at Risk of Breast and/or Ovarian Cancer by Next Generation Sequencing in the Isparta Region

  2021cites this paper
• Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women

  2021cites this paper
• New treatment strategy for ovarian cancer with a BRCA gene mutation

  2021cites this paper
• From BRCA1 to Polygenic Risk Scores: Mutation-Associated Risks in Breast Cancer-Related Genes

  2021cites this paper
• BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis

  2021cites this paper
• A Systematic Review of Breast Cancer Assessment Risk Model

  2021cites this paper
• Identification of Novel BRCA1 Germline Deleterious Variant Among a Tunisian Family

  2021cites this paper
• The effect of eIF3a on anthracycline-based chemotherapy resistance by regulating DSB DNA repair.

  2021cites this paper
• Penetrance of breast cancer genes from the eMERGE III Network

  2021cites this paper
• History of intraperitoneal platinum drug delivery for ovarian cancer and its future applications

  2021cites this paper
• Incidencia de mutaciones genéticas en pacientes con cáncer de mama y ovario con patrón de origen hereditario

  2021cites this paper
• Germline mutations in RAD51C and RAD51D and hereditary predisposition to ovarian cancer.

  2021cites this paper
• DCMP: database of cancer mutant protein domains

  2021cites this paper
• Exome-Wide Pan-Cancer Analysis of Germline Variants in 8,719 Individuals Finds Little Evidence of Rare Variant Associations

  2021cites this paper
• Homologous recombination repair deficiency (HRD): From biology to clinical exploitation

  2021cites this paper
• The Landscape of the Heritable Cancer Genome

  2021cites this paper
• Hereditary Breast and Ovarian Cancer: Current Concepts of Prevention and Treatment

  2021cites this paper
• Use of cellular exosomes as a new carrier in breast cancer gene therapy.

  2021cites this paper
• Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients

  2021cites this paper
• The prevalence of ataxia telangiectasia mutated (ATM) variants in patients with breast cancer patients: a systematic review and meta-analysis

  2021cites this paper
• Study on Male Breast Cancer

  2021cites this paper
• Hereditary Breast-Ovarian Cancer and BRCA1 / BRCA2 variants: a single center experience

  2021cites this paper
• Deep semi-supervised learning ensemble framework for classifying co-mentions of human proteins and phenotypes

  2021cites this paper
• Tumour Versus Germline BRCA Testing in Ovarian Cancer: A Single-Site Institution Experience in the United Kingdom

  2021cites this paper
• Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer

  2021cites this paper
• Retinoblastoma and mosaic 13q deletion: a case report

  2021cites this paper
• Feature Selection for Breast Cancer Classification by Integrating Somatic Mutation and Gene Expression

  2021cites this paper
• Private DNA Sequencing: Hiding Information in Discrete Noise

  2021cites this paper
• Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020

  2021cites this paper
• Sequencing for germline mutations in Swedish breast cancer families reveals novel breast cancer risk genes

  2021cites this paper
• A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2

  2021cites this paper
• An updated review of epidemiology, risk factors, and management of male breast cancer

  2021cites this paper
• The phospho-dependent role of BRCA2 on the maintenance of chromosome integrity

  2021cites this paper
• Targeted Next-generation Sequencing for Reliable Detection of Genetic Status in Breast Cancer.

  2021cites this paper
• History of the methodology of disease gene identification

  2021cites this paper
• Breast cancer in young women Aspects of heredity and contralateral disease

  2021cites this paper
• Prediction of Hereditary Cancers Using Neural Networks

  2021cites this paper
• Polygenic risk in familial breast cancer: Changing the dynamics of communicating genetic risk

  2021cites this paper
• Clinicopathological Features of BRCA1/2 Mutation-Positive Breast Cancer

  2021cites this paper